Alina Biletska
Alina Biletska has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Yaryna Manila
University Clinical Hospital in Krakow, ul. Marii Orwid 1130-688 Kraków Poland
6 shared publications - Iia Zhaharina
University Clinical Hospital No. 2 of Pomeranian Medical University in Szczecin, Szczecin, Poland
5 shared publications - Yuliia Dubova
Wojewódzki Szpital Specjalistyczny im. Janusza Korczaka w Słupsku, Słupsk, Poland
5 shared publications - Aleksandra Kłuś
Silesian Rheumatology Center Gen. Jerzy Ziętek in Ustroń, Poland
4 shared publications - Aneta Kasperska
Mazovian Bródno Hospital in Warsaw, Poland
4 shared publications - Hanna Markowska
Samodzielny Publiczny Wielospecjalistyczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych i Administracji w Bydgoszczy, Poland
4 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (12) , 6928-6936
Long-term staged management of an extensive pelvic and right lower-extremity vascular malformation with major venous abnormalities and postprocedural pulmonary embolism: A case report
- 12 November 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (12) , 6928-6936
Open AccessLong-term staged management of an extensive pelvic and right lower-extremity vascular malformation with major venous abnormalities and postprocedural pulmonary embolism: A case report
- Open Access
- 9 November 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
THE GUT–BRAIN AXIS AND PSYCHOBIOTICS: IMPLICATIONS FOR MENTAL HEALTH – A NARRATIVE REVIEW
Background: The gut–brain axis has emerged as a key regulatory network linking intestinal microbiota with central nervous system activity. Increasing evidence suggests that gut dysbiosis contributes to the pathophysiology of depression and anxiety disorders through mechanisms involving neuroinflammation, hypothalamic–pituitary–adrenal (HPA) axis dysregulation, impaired intestinal barrier integrity, altered tryptophan metabolism, and abnormal microbial metabolite production. Aim: This review aimed to summarize the current evidence regarding the role of the gut–brain axis and psychobiotics in mental health, with particular emphasis on mechanistic pathways and recent clinical studies. Material and methods: A narrative review of the literature indexed in PubMed, Scopus, and Web of Science from 2019 to 2026 was conducted. Particular attention was given to randomized controlled trials, meta-analyses, mechanistic studies, and recent reviews on psychobiotics, gut microbiota, depression, anxiety, neuroinflammation, and precision psychiatry. Results: Current evidence indicates that selected psychobiotic strains, particularly Lactobacillus and Bifidobacterium species, may improve depressive and anxiety symptoms by modulating inflammatory cytokines, microglial activation, vagus nerve signaling, short-chain fatty acid synthesis, and serotonin precursor metabolism. Clinical studies have suggested modest but clinically relevant improvements in mood, cognitive function, stress response, and sleep quality following psychobiotic supplementation. Synbiotic therapy and Mediterranean dietary interventions may further enhance therapeutic outcomes. Conclusions: The gut–brain axis is a promising target in modern psychiatry. Although psychobiotics may constitute a valuable adjunctive strategy for treating depressive and anxiety disorders, further large-scale standardized clinical studies are necessary to establish strain-specific efficacy, optimal treatment duration, and clinically applicable biomarkers.
- 9 November 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessTHE GUT–BRAIN AXIS AND PSYCHOBIOTICS: IMPLICATIONS FOR MENTAL HEALTH – A NARRATIVE REVIEW
Background: The gut–brain axis has emerged as a key regulatory network linking intestinal microbiota with central nervous system activity. Increasing evidence suggests that gut dysbiosis contributes to the pathophysiology of depression and anxiety disorders through mechanisms involving neuroinflammation, hypothalamic–pituitary–adrenal (HPA) axis dysregulation, impaired intestinal barrier integrity, altered tryptophan metabolism, and abnormal microbial metabolite production. Aim: This review aimed to summarize the current evidence regarding the role of the gut–brain axis and psychobiotics in mental health, with particular emphasis on mechanistic pathways and recent clinical studies. Material and methods: A narrative review of the literature indexed in PubMed, Scopus, and Web of Science from 2019 to 2026 was conducted. Particular attention was given to randomized controlled trials, meta-analyses, mechanistic studies, and recent reviews on psychobiotics, gut microbiota, depression, anxiety, neuroinflammation, and precision psychiatry. Results: Current evidence indicates that selected psychobiotic strains, particularly Lactobacillus and Bifidobacterium species, may improve depressive and anxiety symptoms by modulating inflammatory cytokines, microglial activation, vagus nerve signaling, short-chain fatty acid synthesis, and serotonin precursor metabolism. Clinical studies have suggested modest but clinically relevant improvements in mood, cognitive function, stress response, and sleep quality following psychobiotic supplementation. Synbiotic therapy and Mediterranean dietary interventions may further enhance therapeutic outcomes. Conclusions: The gut–brain axis is a promising target in modern psychiatry. Although psychobiotics may constitute a valuable adjunctive strategy for treating depressive and anxiety disorders, further large-scale standardized clinical studies are necessary to establish strain-specific efficacy, optimal treatment duration, and clinically applicable biomarkers.
- Open Access
- 6 November 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
FROM FILTERED SKIN TO COSMETIC PROCEDURE REQUESTS: A NARRATIVE EVIDENCE REVIEW AND CLINICAL SCREENING FRAMEWORK FOR DERMATOLOGY AND AESTHETIC MEDICINE
Background. Image-centered social media have changed how patients observe, edit, compare, and evaluate their appearance [1, 2]. Beauty filters can erase acne, pores, pigment variation, erythema, scars, and lines while also altering facial proportions, creating a continuously available idealized version of the user’s own skin and face [3]. Dermatologists and aesthetic clinicians increasingly encounter procedure requests framed by filtered selfies, influencer content, and videoconferencing images [4, 15]. The popular expression “Snapchat dysmorphia” describes part of this phenomenon but is not a recognized diagnosis and should not be used interchangeably with body dysmorphic disorder (BDD) [1, 2, 37]. Aim. To synthesize evidence along the pathway from digital modification of skin and facial appearance to appearance anxiety and cosmetic procedure requests, and to develop an evidence-informed clinical screening framework for dermatology and aesthetic medicine. Methods. A structured narrative search of PubMed/Google Scholar was conducted through 4 October 2026 using combinations of terms related to social media, filters, selfies, photo editing, skin and facial appearance, appearance anxiety, BDD, cosmetic dermatology, cosmetic surgery, screening, and aesthetic procedures. Reference lists of relevant systematic reviews, meta-analyses, clinical reviews, and professional guidance were examined. Evidence was organized by its position in the proposed clinical pathway: digital exposure and self-editing, appearance comparison and anxiety, procedure consideration, dysmorphic symptoms, and consultation outcomes. Priority was given to systematic reviews and meta-analyses, experimental and longitudinal studies, validated screening research, and clinical guidance. Results. Systematic reviews and experiments indicate that exposure to idealized appearance content can worsen short-term body or facial satisfaction and increase appearance comparison. Active behaviors, including repeated selfie editing and filter use, show more consistent associations with cosmetic procedure acceptance than total social media time. The evidence supports a plausible but not fully established pathway from digital self-modification to self-discrepancy, appearance surveillance, anxiety, and procedure requests. Effect sizes vary, most studies involve young women, and evidence linking filter exposure to completed procedures or long-term psychiatric outcomes remains limited. BDD is substantially overrepresented in dermatology and cosmetic settings. The proposed framework combines assessment of the objective dermatologic finding, digital appearance behaviors, preoccupation and impairment, validated BDD screening, expectations, prior procedures, and mental health risk to guide treatment, extended assessment, deferral, or referral. Conclusions. Filtered skin and facial images should be treated as clinically relevant sources of comparison and procedure expectations rather than as diagnostic entities. The proposed framework translates heterogeneous evidence into a reproducible consultation process. A positive BDD screen does not establish a diagnosis, but probable BDD, an anatomically impossible target, marked functional impairment, acute psychological distress, or self-harm risk should lead to postponement of elective treatment and appropriate mental health assessment.
- 6 November 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessFROM FILTERED SKIN TO COSMETIC PROCEDURE REQUESTS: A NARRATIVE EVIDENCE REVIEW AND CLINICAL SCREENING FRAMEWORK FOR DERMATOLOGY AND AESTHETIC MEDICINE
Background. Image-centered social media have changed how patients observe, edit, compare, and evaluate their appearance [1, 2]. Beauty filters can erase acne, pores, pigment variation, erythema, scars, and lines while also altering facial proportions, creating a continuously available idealized version of the user’s own skin and face [3]. Dermatologists and aesthetic clinicians increasingly encounter procedure requests framed by filtered selfies, influencer content, and videoconferencing images [4, 15]. The popular expression “Snapchat dysmorphia” describes part of this phenomenon but is not a recognized diagnosis and should not be used interchangeably with body dysmorphic disorder (BDD) [1, 2, 37]. Aim. To synthesize evidence along the pathway from digital modification of skin and facial appearance to appearance anxiety and cosmetic procedure requests, and to develop an evidence-informed clinical screening framework for dermatology and aesthetic medicine. Methods. A structured narrative search of PubMed/Google Scholar was conducted through 4 October 2026 using combinations of terms related to social media, filters, selfies, photo editing, skin and facial appearance, appearance anxiety, BDD, cosmetic dermatology, cosmetic surgery, screening, and aesthetic procedures. Reference lists of relevant systematic reviews, meta-analyses, clinical reviews, and professional guidance were examined. Evidence was organized by its position in the proposed clinical pathway: digital exposure and self-editing, appearance comparison and anxiety, procedure consideration, dysmorphic symptoms, and consultation outcomes. Priority was given to systematic reviews and meta-analyses, experimental and longitudinal studies, validated screening research, and clinical guidance. Results. Systematic reviews and experiments indicate that exposure to idealized appearance content can worsen short-term body or facial satisfaction and increase appearance comparison. Active behaviors, including repeated selfie editing and filter use, show more consistent associations with cosmetic procedure acceptance than total social media time. The evidence supports a plausible but not fully established pathway from digital self-modification to self-discrepancy, appearance surveillance, anxiety, and procedure requests. Effect sizes vary, most studies involve young women, and evidence linking filter exposure to completed procedures or long-term psychiatric outcomes remains limited. BDD is substantially overrepresented in dermatology and cosmetic settings. The proposed framework combines assessment of the objective dermatologic finding, digital appearance behaviors, preoccupation and impairment, validated BDD screening, expectations, prior procedures, and mental health risk to guide treatment, extended assessment, deferral, or referral. Conclusions. Filtered skin and facial images should be treated as clinically relevant sources of comparison and procedure expectations rather than as diagnostic entities. The proposed framework translates heterogeneous evidence into a reproducible consultation process. A positive BDD screen does not establish a diagnosis, but probable BDD, an anatomically impossible target, marked functional impairment, acute psychological distress, or self-harm risk should lead to postponement of elective treatment and appropriate mental health assessment.
- Open Access
- 26 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME — A NARRATIVE REVIEW OF MECHANISMS AND MANAGEMENT
Polycystic ovary syndrome (PCOS) affects 11–13% of women of reproductive age worldwide and combines hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Once viewed as a purely reproductive disorder, PCOS is now also recognised as a metabolic one, with insulin resistance (IR) and compensatory hyperinsulinaemia linking its reproductive and metabolic features. In a 2026 international consensus published in The Lancet, the condition was formally renamed polyendocrine metabolic ovarian syndrome (PMOS); the term PCOS remains widely used during the announced three-year transition period. This narrative review synthesises current evidence on the role of insulin resistance in the pathophysiology of PCOS, with a focus on the 2023 International Evidence-based Guideline and recent pharmacological developments. We searched PubMed, Scopus and Google Scholar for peer-reviewed literature published in English between January 2004 and April 2026, prioritising original studies, systematic reviews, meta-analyses and current clinical guidelines. Hyperinsulinaemia stimulates ovarian theca-cell androgen production and lowers hepatic sex hormone-binding globulin synthesis, raising bioavailable androgens. A pathway-selective insulin signalling defect — impaired PI3K/Akt with relatively preserved MAPK signalling — has been proposed as a unifying molecular mechanism. Lifestyle modification remains first-line therapy; metformin and inositol improve metabolic and ovulatory parameters, and glucagon-like peptide-1 receptor agonists produce greater reductions in body weight and HOMA-IR than metformin in head-to-head studies. Insulin resistance is a key driver of both reproductive and metabolic outcomes, and early identification is essential for reducing long-term cardiometabolic morbidity.
- 26 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessINSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME — A NARRATIVE REVIEW OF MECHANISMS AND MANAGEMENT
Polycystic ovary syndrome (PCOS) affects 11–13% of women of reproductive age worldwide and combines hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Once viewed as a purely reproductive disorder, PCOS is now also recognised as a metabolic one, with insulin resistance (IR) and compensatory hyperinsulinaemia linking its reproductive and metabolic features. In a 2026 international consensus published in The Lancet, the condition was formally renamed polyendocrine metabolic ovarian syndrome (PMOS); the term PCOS remains widely used during the announced three-year transition period. This narrative review synthesises current evidence on the role of insulin resistance in the pathophysiology of PCOS, with a focus on the 2023 International Evidence-based Guideline and recent pharmacological developments. We searched PubMed, Scopus and Google Scholar for peer-reviewed literature published in English between January 2004 and April 2026, prioritising original studies, systematic reviews, meta-analyses and current clinical guidelines. Hyperinsulinaemia stimulates ovarian theca-cell androgen production and lowers hepatic sex hormone-binding globulin synthesis, raising bioavailable androgens. A pathway-selective insulin signalling defect — impaired PI3K/Akt with relatively preserved MAPK signalling — has been proposed as a unifying molecular mechanism. Lifestyle modification remains first-line therapy; metformin and inositol improve metabolic and ovulatory parameters, and glucagon-like peptide-1 receptor agonists produce greater reductions in body weight and HOMA-IR than metformin in head-to-head studies. Insulin resistance is a key driver of both reproductive and metabolic outcomes, and early identification is essential for reducing long-term cardiometabolic morbidity.
- Open Access
- 21 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
THE ROLE OF PHYSICAL ACTIVITY IN SLOWING PROGRESSION OF CHRONIC KIDNEY DISEASE - A NARRATIVE REVIEW
Chronic kidney disease (CKD) represents a substantial and growing global health dysfunction. The rising occurrence driven by aging populations and increasing rates of metabolic disorders. This disease causes kidney function to slowly get worse. In the early stages, there are often no symptoms, so it is usually diagnosed only after significant kidney damage has already happened. Current clinical and public health strategies prioritize early identification and risk reduction. Modifiable lifestyle factors - such as regular physical activity and effective weight management - play an important role in slowing disease progression and reducing the risk of end-stage renal disease requiring dialysis or kidney transplantation. This narrative review aims to investigate the relationship between physical activity and the slowing of chronic kidney disease progression in patients. This narrative review evaluates scientific literature published over the past 25 years. Relevant data were obtained from studies indexed in the PubMed and Scopus databases. Cohort studies, systematic reviews, and meta-analyses published in English were included. Across the analyzed studies, greater engagement in physical activity was consistently linked to lower all-cause mortality in patients with chronic kidney disease. Active individuals tended to report better quality of life and exhibited a more gradual reduction in kidney function compared to those with lower activity levels, which indicates that regular physical activity is associated with improved patient prognosis. Physical activity has been consistently connected to lower death rates in people with chronic kidney disease. In addition, higher levels of physical activity relate to better quality of life and a slower rate of disease progression when compared to inactive patients.
- 21 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessTHE ROLE OF PHYSICAL ACTIVITY IN SLOWING PROGRESSION OF CHRONIC KIDNEY DISEASE - A NARRATIVE REVIEW
Chronic kidney disease (CKD) represents a substantial and growing global health dysfunction. The rising occurrence driven by aging populations and increasing rates of metabolic disorders. This disease causes kidney function to slowly get worse. In the early stages, there are often no symptoms, so it is usually diagnosed only after significant kidney damage has already happened. Current clinical and public health strategies prioritize early identification and risk reduction. Modifiable lifestyle factors - such as regular physical activity and effective weight management - play an important role in slowing disease progression and reducing the risk of end-stage renal disease requiring dialysis or kidney transplantation. This narrative review aims to investigate the relationship between physical activity and the slowing of chronic kidney disease progression in patients. This narrative review evaluates scientific literature published over the past 25 years. Relevant data were obtained from studies indexed in the PubMed and Scopus databases. Cohort studies, systematic reviews, and meta-analyses published in English were included. Across the analyzed studies, greater engagement in physical activity was consistently linked to lower all-cause mortality in patients with chronic kidney disease. Active individuals tended to report better quality of life and exhibited a more gradual reduction in kidney function compared to those with lower activity levels, which indicates that regular physical activity is associated with improved patient prognosis. Physical activity has been consistently connected to lower death rates in people with chronic kidney disease. In addition, higher levels of physical activity relate to better quality of life and a slower rate of disease progression when compared to inactive patients.
- Open Access
- 20 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
THE ROLE OF DIGITAL TECHNOLOGIES IN THE PREVENTION AND MANAGEMENT OF OBESITY AMONG CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW OF STUDIES FROM 2010–2026
Childhood and adolescent obesity represents a growing global public health challenge associated with numerous metabolic, behavioral, and psychosocial consequences. In recent years, digital health technologies have increasingly been implemented as tools supporting obesity prevention and management among pediatric populations. The aim of this systematic review was to evaluate the role and effectiveness of digital health interventions in the prevention and management of obesity among children and adolescents, with particular attention to intervention type, target population, measured outcomes, and social implications. A systematic literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, and PsycINFO in accordance with PRISMA 2020 guidelines. Original empirical studies published between 2010 and 2026 involving participants aged 2–18 years were included. A total of 22 original empirical studies published between 2010 and 2026 were included in the qualitative synthesis. The analyzed interventions comprised mobile health applications, telemedicine, internet-based educational programs, text-message interventions, and active video games. The included studies demonstrated that digital interventions may positively influence obesity-related outcomes, including body mass index (BMI), physical activity, dietary behaviors, self-monitoring, motivation, and adherence to lifestyle modification programs. Telemedicine and mobile health approaches additionally improved accessibility to obesity management services, particularly in underserved populations. Despite promising findings, considerable heterogeneity in study design, intervention duration, and outcome assessment was identified. Further large-scale longitudinal studies are needed to evaluate the long-term effectiveness and sustainability of digital obesity interventions among children and adolescents.
- 20 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessTHE ROLE OF DIGITAL TECHNOLOGIES IN THE PREVENTION AND MANAGEMENT OF OBESITY AMONG CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW OF STUDIES FROM 2010–2026
Childhood and adolescent obesity represents a growing global public health challenge associated with numerous metabolic, behavioral, and psychosocial consequences. In recent years, digital health technologies have increasingly been implemented as tools supporting obesity prevention and management among pediatric populations. The aim of this systematic review was to evaluate the role and effectiveness of digital health interventions in the prevention and management of obesity among children and adolescents, with particular attention to intervention type, target population, measured outcomes, and social implications. A systematic literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, and PsycINFO in accordance with PRISMA 2020 guidelines. Original empirical studies published between 2010 and 2026 involving participants aged 2–18 years were included. A total of 22 original empirical studies published between 2010 and 2026 were included in the qualitative synthesis. The analyzed interventions comprised mobile health applications, telemedicine, internet-based educational programs, text-message interventions, and active video games. The included studies demonstrated that digital interventions may positively influence obesity-related outcomes, including body mass index (BMI), physical activity, dietary behaviors, self-monitoring, motivation, and adherence to lifestyle modification programs. Telemedicine and mobile health approaches additionally improved accessibility to obesity management services, particularly in underserved populations. Despite promising findings, considerable heterogeneity in study design, intervention duration, and outcome assessment was identified. Further large-scale longitudinal studies are needed to evaluate the long-term effectiveness and sustainability of digital obesity interventions among children and adolescents.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
CHRONIC PSYCHOLOGICAL STRESS AND FEMALE REPRODUCTIVE DYSFUNCTION: EFFECTS ON OVARIAN RESERVE – A NARRATIVE REVIEW
Chronic psychological stress negatively affects systems including the female reproductive axis. Ovarian reserve, reflecting oocyte quantity and quality, is a determinant of fertility and reproductive aging. In contemporary society, uncertainty, economic instability, poor work-life balance, and expanding social roles of women contribute to delayed childbearing and attention to age-related fertility decline. This review evaluates the impact and long-term consequences of chronic psychological stress on ovarian reserve and reproductive aging in women. A narrative review was performed using PubMed and Scopus. The search included publications from the past 20 years on chronic psychological stress, ovarian reserve, ovarian dysfunction, premature ovarian insufficiency, and reproductive aging. Guidelines, original studies, and reviews were analyzed. Studies suggest that women exposed to chronic stress often report increased perceived stress before reproductive dysfunction appears. Clinical and demographic data indicate that chronic stress, emotional trauma, and major life events may contribute to ovarian dysfunction and act as triggers of premature ovarian insufficiency. These factors are associated with reduced ovarian reserve markers and hormonal changes, including altered AMH, FSH, and cortisol. Overall, evidence supports a possible link between chronic psychological stress and accelerated reproductive aging, although findings remain heterogeneous due to differences in study design, stress assessment, populations, and outcomes. Chronic stress appears to be associated with impaired ovarian function, decreased ovarian reserve, and earlier reproductive aging. These findings underline the need to identify at-risk women and integrate stress management, support, and preventive counseling into reproductive health care. Further studies are needed to clarify mechanisms, define biomarkers, and guide clinical practice.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessCHRONIC PSYCHOLOGICAL STRESS AND FEMALE REPRODUCTIVE DYSFUNCTION: EFFECTS ON OVARIAN RESERVE – A NARRATIVE REVIEW
Chronic psychological stress negatively affects systems including the female reproductive axis. Ovarian reserve, reflecting oocyte quantity and quality, is a determinant of fertility and reproductive aging. In contemporary society, uncertainty, economic instability, poor work-life balance, and expanding social roles of women contribute to delayed childbearing and attention to age-related fertility decline. This review evaluates the impact and long-term consequences of chronic psychological stress on ovarian reserve and reproductive aging in women. A narrative review was performed using PubMed and Scopus. The search included publications from the past 20 years on chronic psychological stress, ovarian reserve, ovarian dysfunction, premature ovarian insufficiency, and reproductive aging. Guidelines, original studies, and reviews were analyzed. Studies suggest that women exposed to chronic stress often report increased perceived stress before reproductive dysfunction appears. Clinical and demographic data indicate that chronic stress, emotional trauma, and major life events may contribute to ovarian dysfunction and act as triggers of premature ovarian insufficiency. These factors are associated with reduced ovarian reserve markers and hormonal changes, including altered AMH, FSH, and cortisol. Overall, evidence supports a possible link between chronic psychological stress and accelerated reproductive aging, although findings remain heterogeneous due to differences in study design, stress assessment, populations, and outcomes. Chronic stress appears to be associated with impaired ovarian function, decreased ovarian reserve, and earlier reproductive aging. These findings underline the need to identify at-risk women and integrate stress management, support, and preventive counseling into reproductive health care. Further studies are needed to clarify mechanisms, define biomarkers, and guide clinical practice.